Peptide & GLP-1 Side Effects
A plain-language reference to the adverse effects most commonly reported for peptides and GLP-1 medications, grouped by compound class. Create a free account to log and track your own effects, severity, and dates over time.
Loading your Adverse Effect Tracker
Sign in to log a compound, effect, severity, and date, then review your history and trends. The reference below is free to read.
GLP-1 & incretin agonists
Semaglutide, tirzepatide, and retatrutide most often cause dose-dependent gastrointestinal effects, especially when starting or increasing a dose. These usually ease as the body adjusts and are a common reason protocols titrate slowly.
- NauseaModerate
- The most frequently reported effect, usually strongest in the first days after a dose increase and often improving with slower titration.
- VomitingModerate
- Reported particularly at higher doses or after rapid escalation; persistent vomiting warrants professional review for dehydration.
- Diarrhea or constipationMild
- Altered bowel habits are common as gastric emptying slows; adequate fluids and fiber are commonly discussed mitigations.
- Reduced appetite and early satietyMild
- An expected pharmacologic effect that can become a concern if intake drops too low to maintain nutrition.
- Injection-site reactionMild
- Redness, itching, or a small lump at the injection site, generally transient and reduced by rotating sites.
- Gallbladder problemsSevere
- Rapid weight loss is associated with gallstones; severe upper-right abdominal pain should be evaluated urgently.
- Pancreatitis (rare)Severe
- Severe, persistent abdominal pain radiating to the back has been reported rarely and requires immediate medical attention.
Growth hormone secretagogues
Ipamorelin, CJC-1295, sermorelin, tesamorelin, hexarelin, and similar GHRH/ghrelin-pathway compounds are researched for growth hormone release. Reported effects are often related to fluid balance and the hormone pulse itself.
- Water retention or swellingMild
- Mild edema, puffiness, or a feeling of fullness in the hands can accompany elevated growth hormone activity.
- Numbness or tinglingMild
- Transient paresthesia, sometimes described as carpal-tunnel-like, has been reported and is often dose-related.
- Head rush or flushingMild
- A brief warmth or lightheaded feeling shortly after injection, particularly with more potent secretagogues.
- Injection-site reactionMild
- Local redness or irritation that typically resolves quickly and is reduced by rotating sites.
- Increased hungerMild
- Ghrelin-pathway compounds can transiently increase appetite because ghrelin is a hunger signal.
- Fatigue or drowsinessMild
- Some report tiredness after dosing, which is one reason many secretagogues are taken before sleep.
Healing & recovery peptides
BPC-157, TB-500, and popular recovery blends and stacks are researched for tissue repair. Reported effects are generally mild and often centered on the injection itself.
- Injection-site reactionMild
- Local redness, soreness, or a small bump, generally transient and reduced by rotating sites.
- LightheadednessMild
- A brief dizzy feeling shortly after dosing that usually passes quickly.
- FatigueMild
- Some report short-lived tiredness, particularly early in a protocol.
- HeadacheMild
- Mild, transient headaches are occasionally reported and often resolve with hydration.
- NauseaMild
- Occasional, mild stomach upset that generally does not persist.
Cosmetic & skin peptides
GHK-Cu, PT-141, Melanotan II, and related compounds are researched for skin, pigmentation, or sexual health. Effects vary widely by compound and are noted here at a class level.
- Nausea and flushingModerate
- Reported notably with PT-141 and Melanotan II, sometimes strongest with early doses.
- Skin darkening or new molesModerate
- Melanotan II can darken skin and existing moles or freckles; new or changing moles should be checked by a professional.
- Injection-site reactionMild
- Local redness, itching, or irritation that typically resolves quickly.
- Blood pressure changesModerate
- PT-141 has been associated with transient increases in blood pressure and decreases in heart rate around dosing.
- HeadacheMild
- Mild, transient headaches are occasionally reported across this class.
Metabolic & longevity peptides
MOTS-c, SS-31, and Epitalon are researched for mitochondrial function, metabolism, and longevity. Human safety data is limited, so reported effects are described conservatively.
- Injection-site reactionMild
- Local redness or soreness that typically resolves quickly and is reduced by rotating sites.
- FatigueMild
- Transient tiredness has been reported and generally does not persist.
- HeadacheMild
- Mild, transient headaches are occasionally reported.
- FlushingMild
- A brief warm sensation shortly after dosing, most noted with faster infusions of SS-31.
Common questions
- What are the most common side effects of peptides and GLP-1 medications?
- Across GLP-1 medications such as semaglutide and tirzepatide, the most common side effects are gastrointestinal: nausea, vomiting, diarrhea, constipation, and reduced appetite, usually strongest after a dose increase. For research peptides, the most commonly reported effects are mild and local, such as injection-site redness, lightheadedness, headache, or fatigue.
- Why do GLP-1 side effects happen when increasing the dose?
- GLP-1 and dual/triple agonists slow gastric emptying and act on appetite pathways, so gastrointestinal effects are dose-dependent. They tend to appear or intensify shortly after a dose increase and ease as the body adjusts, which is why protocols typically titrate the dose upward slowly.
- How can I reduce injection-site reactions?
- Rotating injection sites, letting the solution reach room temperature, using a clean technique, and avoiding repeat injections in the same spot are commonly discussed ways to reduce local redness, soreness, and lumps. Persistent or spreading reactions should be reviewed by a professional.
- Which side effects are serious and need medical attention?
- Severe, persistent abdominal pain (possible gallbladder problems or pancreatitis), signs of an allergic reaction, severe or persistent vomiting with dehydration, chest pain, or new and changing moles are examples of effects that warrant prompt professional evaluation. This page is educational and not a substitute for medical advice.
- Can I track my own side effects on Keel?
- Yes. With a free account you can log the compound, effect, severity, date, and notes for anything you experience, then review a reverse-chronological history and lightweight trends over time. Your logs are private to your account.
Ready to dose? Use the Dose & Reconstitution Calculator or browse the compound library.
For educational and research purposes only. Not medical advice. Always consult a licensed healthcare professional.